(Q38237224)

31 August 2017

title

Retinal manifestations of Alzheimer's disease (English)

1 reference

31 August 2017

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25095818%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

M Francesca Cordeiro

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25095818%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Mohammad H Dehabadi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25095818%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Timothy K Wong

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25095818%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

1 January 2014

1 reference

Neurodegenerative disease management

31 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25095818%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25095818%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25095818%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

241-252

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25095818%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference

Synaptic memory mechanisms: Alzheimer's disease amyloid beta-peptide-induced dysfunction

21 January 2018

1 reference

Neurodegeneration and Alzheimer's disease: the lesson from tauopathies

21 January 2018

1 reference

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

Enhanced amyloidogenic processing of the beta-amyloid precursor protein in gene-targeted mice bearing the Swedish familial Alzheimer's disease mutations and a "humanized" Abeta sequence

21 January 2018

1 reference

Alzheimer's disease in the retina: imaging retinal aβ plaques for early diagnosis and therapy assessment

21 January 2018

1 reference

Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study

21 January 2018

1 reference

Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study

21 January 2018

1 reference

Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play

21 January 2018

1 reference

The role of biomarkers in clinical trials for Alzheimer disease

21 January 2018

1 reference

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

Amyloid imaging in early detection of Alzheimer's disease

21 January 2018

1 reference

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease

21 January 2018

1 reference

Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease.

21 January 2018

1 reference

CSF biomarker levels in early and late onset Alzheimer's disease

21 January 2018

1 reference

CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease

21 January 2018

1 reference

Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease

21 January 2018

1 reference

Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent.

21 January 2018

1 reference

FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease

21 January 2018

1 reference

Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease.

21 January 2018

1 reference

Spatial pattern of cerebral glucose metabolism (PET) correlates with localization of intracerebral EEG-generators in Alzheimer's disease.

21 January 2018

1 reference

A novel MRI-biomarker candidate for Alzheimer's disease composed of regional brain volume and perfusion variables

21 January 2018

1 reference

Longitudinal regional brain volume changes quantified in normal aging and Alzheimer's APP x PS1 mice using MRI.

21 January 2018

1 reference

Parallel findings in age-related macular degeneration and Alzheimer's disease

21 January 2018

1 reference

Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures.

21 January 2018

1 reference

Imaging multiple phases of neurodegeneration: a novel approach to assessing cell death in vivo

21 January 2018

1 reference

Imaging apoptosis in the eye.

21 January 2018

1 reference

Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model

21 January 2018

1 reference

Effect of oral donepezil on intraocular pressure in normotensive Alzheimer patients

21 January 2018

1 reference

Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons

21 January 2018

1 reference

Study of neuroprotection of donepezil, a therapy for Alzheimer's disease

21 January 2018

1 reference

Optic-nerve degeneration in Alzheimer's disease.

21 January 2018

1 reference

Optic nerve damage in Alzheimer's disease

21 January 2018

1 reference

Retinal ganglion cell degeneration in Alzheimer's disease

21 January 2018

1 reference

Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL.

21 January 2018

1 reference

Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina

21 January 2018

1 reference

Protein aggregation in the aging retina.

21 January 2018

1 reference

Ocular changes in TgF344-AD rat model of Alzheimer's disease

21 January 2018

1 reference

Long-term in vivo imaging of fibrillar tau in the retina of P301S transgenic mice

21 January 2018

1 reference

Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer's and Parkinson's disease patients

21 January 2018

1 reference

Optical coherence tomography and histologic measurements of nerve fiber layer thickness in normal and glaucomatous monkey eyes

21 January 2018

1 reference

Retinal nerve fiber layer analysis: relationship between optical coherence tomography and red-free photography.

21 January 2018

1 reference

Ultrahigh-resolution ophthalmic optical coherence tomography

21 January 2018

1 reference

Optical imaging to evaluate retinal activation by electrical currents using suprachoroidal-transretinal stimulation

21 January 2018

1 reference

Optophysiology: depth-resolved probing of retinal physiology with functional ultrahigh-resolution optical coherence tomography

21 January 2018

1 reference

In vivo total retinal blood flow measurement by Fourier domain Doppler optical coherence tomography

21 January 2018

1 reference

Measurement of the hemoglobin oxygen saturation level with spectroscopic spectral-domain optical coherence tomography.

21 January 2018

1 reference

Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease.

21 January 2018

1 reference

Morphological and functional retinal impairment in Alzheimer's disease patients

21 January 2018

1 reference

Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

Neuroimaging of retinal nerve fiber layer in AD using optical coherence tomography.

21 January 2018

1 reference

Retinal nerve fiber layer structure abnormalities in early Alzheimer's disease: evidence in optical coherence tomography

21 January 2018

1 reference

Retinal abnormalities in early Alzheimer's disease

21 January 2018

1 reference

Detection of Retinal Nerve Fiber Layer Defects in Alzheimer's Disease Using SD-OCT.

21 January 2018

1 reference

Structural and functional impairment of the retina and optic nerve in Alzheimer's disease.

21 January 2018

1 reference

Optical coherence tomography of the retina: applications in neurology

21 January 2018

1 reference

Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging

21 January 2018

1 reference

Pathophysiology of neuronal energy crisis in Alzheimer's disease

21 January 2018

1 reference

Retinal nerve fiber layer abnormalities in Alzheimer's disease.

21 January 2018

1 reference

Optic nerve head and nerve fiber layer in Alzheimer's disease

21 January 2018

1 reference

Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease.

21 January 2018

1 reference

Ophthalmologic manifestations of Alzheimer's disease

21 January 2018

1 reference

Visual field limitation in the patient with dementia of the Alzheimer's type.

21 January 2018

1 reference

Visual contrast sensitivity in Alzheimer's disease, mild cognitive impairment, and older adults with cognitive complaints

21 January 2018

1 reference

Abnormal pattern electroretinogram in Alzheimer's disease: evidence for retinal ganglion cell degeneration?

21 January 2018

1 reference

Abnormal pattern electroretinograms in patients with senile dementia of the Alzheimer type.

21 January 2018

1 reference

Visual cortical dysfunction in Alzheimer's disease evaluated with a temporally graded "stress test" during PET.

21 January 2018

1 reference

Animal models in the drug discovery pipeline for Alzheimer's disease

21 January 2018

1 reference

Alzheimer's disease: genetic studies and transgenic models

21 January 2018

1 reference

Tauopathy models and human neuropathology: similarities and differences

21 January 2018

1 reference

Alzheimer disease models and human neuropathology: similarities and differences

21 January 2018

1 reference

Transgenic models of Alzheimer's disease: learning from animals

21 January 2018

1 reference

Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice

21 January 2018

1 reference

Tau inclusions in retinal ganglion cells of human P301S tau transgenic mice: effects on axonal viability.

21 January 2018

1 reference

Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease

21 January 2018

1 reference

Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease

21 January 2018

1 reference

Reduced retinal function in amyloid precursor protein-over-expressing transgenic mice via attenuating glutamate-N-methyl-d-aspartate receptor signaling

21 January 2018

1 reference

Reduced axonal transport and increased excitotoxic retinal ganglion cell degeneration in mice transgenic for human mutant P301S tau.

21 January 2018

1 reference

Retinal ganglion cell dendritic degeneration in a mouse model of Alzheimer's disease.

21 January 2018

1 reference

Hyperphosphorylation of tau protein by calpain regulation in retina of Alzheimer's disease transgenic mouse

21 January 2018

1 reference

Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer's disease

21 January 2018

1 reference

Neurodegeneration of the retina in mouse models of Alzheimer's disease: what can we learn from the retina?

21 January 2018

1 reference

Viewing Ageing Eyes: Diverse Sites of Amyloid Beta Accumulation in the Ageing Mouse Retina and the Up-Regulation of Macrophages

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/NMT.14.19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25095818%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference